Using the CTD database, we searched possible drugs that could upregulate EED or HSPA1B expression and downregulate CSF3R or IL17RA expression, respectively, since CSF3R and IL17RA are risk factors and EED and HSPA1B are protective factors in CAD. This evidence concerns the gene HSPA1B and coronary artery disorder.